Trial intelligence / Profile preview

Hemostatic Parameters of EV/DNG vs EE/LNG in Healthy Females

NCT00318799Phase 2Completed

Sponsor
Bayer
Start
Apr 2006
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of estradiol valerate + dienogest, sponsored by Bayer. Started Apr 2006; status: completed.

02

Drugs

estradiol valerate + dienogest

Beyond the preview

Go deeper on NCT00318799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00318799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call